Fifth Lane Capital, LP Agile Therapeutics Inc Transaction History

Fifth Lane Capital, LP

  • $37.3 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.28 - $14.85 $2,800 - $148,500
10,000 New
10,000 $0

About AGILE THERAPEUTICS INC

AGRX Quotes by TradingView
  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track This Portfolio

Track Fifth Lane Capital, LP Portfolio

Follow Fifth Lane Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Lane Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Lane Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email